☰

Barbara Chatfield - Publications

Affiliations: 
University of Utah, Salt Lake City, UT 
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Liou TG, Argel N, Asfour F, Brown PS, Chatfield BA, Cox DR, Daines CL, Durham D, Francis JA, Glover B, Helms M, Heynekamp T, Hoidal JR, Jensen JL, Kartsonaki C, et al. Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis. Iscience. 27: 108835. PMID 38384849 DOI: 10.1016/j.isci.2024.108835  0.338
2019 Liou TG, Adler FR, Argel N, Asfour F, Brown PS, Chatfield BA, Daines CL, Durham D, Francis JA, Glover B, Heynekamp T, Hoidal JR, Jensen JL, Keogh R, Kopecky CM, et al. Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis. Bmc Medical Research Methodology. 19: 88. PMID 31027503 DOI: 10.1186/S12874-019-0705-0  0.343
2016 Liou TG, Jensen JL, Allen SE, Brayshaw SJ, Brown MA, Chatfield B, Koenig J, McDonald C, Packer KA, Peet K, Radford P, Reineke LM, Otsuka K, Wagener JS, Young D, et al. Improving performance in the detection and management of cystic fibrosis-related diabetes in the Mountain West Cystic Fibrosis Consortium. Bmj Open Diabetes Research & Care. 4: e000183. PMID 27158517 DOI: 10.1136/Bmjdrc-2015-000183  0.327
2015 Conrad C, Lymp J, Thompson V, Dunn C, Davies Z, Chatfield B, Nichols D, Clancy J, Vender R, Egan ME, Quittell L, Michelson P, Antony V, Spahr J, Rubenstein RC, et al. Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 14: 219-27. PMID 25228446 DOI: 10.1016/J.Jcf.2014.08.008  0.365
2011 Borowitz D, Stevens C, Brettman LR, Campion M, Chatfield B, Cipolli M. International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 10: 443-52. PMID 21831726 DOI: 10.1016/J.Jcf.2011.07.001  0.433
2009 Wooldridge JL, Heubi JE, Amaro-Galvez R, Boas SR, Blake KV, Nasr SZ, Chatfield B, McColley SA, Woo MS, Hardy KA, Kravitz RM, Straforini C, Anelli M, Lee C. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 8: 405-17. PMID 19683970 DOI: 10.1016/J.Jcf.2009.07.006  0.38
2007 Wooldridge J, Amaro-Galvez R, Blake K, Chatfield B, McColley S, Woo M, Straforini C, Anelli M. 245 A phase III trial of EUR-1008 in young cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (EPI) Journal of Cystic Fibrosis. 6: S60. DOI: 10.1016/S1569-1993(07)60228-8  0.443
2006 Hardin DS, Adams-Huet B, Brown D, Chatfield B, Dyson M, Ferkol T, Howenstine M, Prestidge C, Royce F, Rice J, Seilheimer DK, Steelman J, Shepherds R. Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial. The Journal of Clinical Endocrinology and Metabolism. 91: 4925-9. PMID 17018651 DOI: 10.1210/Jc.2006-1101  0.363
Show low-probability matches.